The Rcs-signaling system is one of the most remarkable phosphorelay pathways in Enterobacteriaceae, comprising several membrane-bound and soluble proteins. Within the complex phosphotransfer pathway, the histidine phosphotransferase (HPt) domain of the RcsD membrane-bound component serves as a crucial factor in modulating the phosphorylation state of the transcription factor RcsB. We have identified a new domain, RcsD-ABL, located N terminally to RcsD-HPt that interacts with RcsB as well. We have determined its structure, characterized its interaction interface with RcsB, and built a structural model of the complex of the RcsD-ABL domain with RcsB. Our results indicate that the effector domain of RcsB, which normally binds to DNA, is recognized by RcsD-ABL, whereas the HPt domain interacts with the phosphoreceiver domain of RcsB.
INTRODUCTION
Bacteria live in habitats with frequently changing environmental conditions and, consequently, have developed elaborate strategies to survive. To obtain information about changes in the environment, bacteria use a whole array of membrane-bound receptors that transfer information to the cellular interior by a phosphorylation cascade. These phosphotransfer pathways are referred to as two-component systems (West and Stock, 2001 ) and usually involve two proteins: a membrane-bound sensor histidine kinase (HK), and a cytoplasmic-response regulator. After receiving an external stimulus, for example, via a signal recognition domain, the signal response is generated by autophosphorylation of a conserved histidine residue in the HK domain. Subsequently, this phosphoryl group is transferred to a conserved aspartic acid in the phosphoreceiver (PR) domain of a response regulator, usually a soluble transcription factor in the cytoplasm. The phosphorylation of this aspartic acid leads to conformational changes in the effector domain, followed by binding to specific promoter regions on the DNA (Stock et al., 1989) . An additional regulatory level is the requirement for most transcription factors and HKs to form homodimers (and also heterodimers in the case of some transcription factors) to interact effectively with the DNA or to promote the phosphorelay (Clarke et al., 2002; Khorchid et al., 2005; Maris et al., 2005; Tomomori et al., 1999; Wehland et al., 1999) . Prominent examples for such two-component systems are the EnvZ/OmpR (Egger et al., 1997) and FixL/FixJ (Nixon et al., 1986) systems. Besides the basic two-component systems, more complex HKs exist that contain in addition to the HK domain a PR domain and a histidine phosphotransferase (HPt) domain, which can also exist as a separate protein . These so-called hybrid sensor kinases contain multiple phosphodonor and acceptor sites and use multistep phosphorelay schemes mediated by a His-Asp-His-Asp cascade rather than promoting a single phosphotransfer. They likely provide advantages such as increasing the variety of signaling strategies, allowing greater levels of control, and more checkpoints for the input of information (Grebe and Stock, 1999; Zhang and Shi, 2005) . Some prominent examples are the multistep phosphorelays of Sln1-Ypd1-Ssk1 from S. cerevisiae (Zhao et al., 2008) and of KinA-Spo0F-Spo0B-Spo0A from B. subtilis (Stephenson and Hoch, 2002; Varughese et al., 2006; Zapf et al., 2000) , as well as the ArcB/ArcA (Iuchi, 1993; Iuchi and Lin, 1992) and BvgS/ BvgA (Uhl and Miller, 1996) systems. Especially for the KinASpo0F-Spo0B-Spo0A phosphorelay, many kinases and phosphatases have been discovered that clearly demonstrate the additional level of control (Krell et al., 2010) . Among multistep phosphorelays, the highly complex regulator system Rcs is unique. Originally believed to be a regulator of capsule synthesis in Enterobacteriaceae, the Rcs phosphorelay has also been found to be involved in transcriptional networks in cell division, motility, biofilm formation, and virulence . Recently, the Rcs phosphorelay has been implicated in the peptidoglycan stress response induced either by b-lactam antibiotics or by exposure to lysozyme followed by regulation of expression of lysozyme inhibitors (Callewaert et al., 2009; Laubacher and Ades, 2008) . However, the exact stimulus of this complex pathway is still unknown. Therefore, investigation of the regulatory mechanisms of the phosphorelay is of particular importance. Contrary to classical two-component systems, the Rcs-signaling pathway in E. coli involves a His-Asp-His-Asp cascade (Figure 1 ) (Chen et al., 2001) and is composed of the five proteins RcsF, RcsC, RcsD, RcsB, and RcsA. The outer membrane protein RcsF is described as a lipoprotein involved in activation of RcsC (Castanie-Cornet et al., 2006; . After activation, the signal is passed on to the sensor domains of the membrane-bound RcsC and/or RcsD proteins. The hybrid sensor kinase RcsC gets autophosphorylated at His479 before the phosphoryl group is transferred to Asp875 in its PR domain. From here, the phosphoryl group is transferred to His842 in the HPt domain of RcsD, which cannot autophosphorylate because its kinase domain does not contain the canonical active site histidine (Figure 1 ). The HPt domain facilitates the transfer of the phosphoryl group from RcsD to the conserved aspartic residue Asp56 of the PR domain of the transcription factor RcsB. Depending on its phosphorylation state, RcsB binds either alone to the DNA or together with the accessory protein RcsA to the RcsAB box motif (Pristovsek et al., 2003; Wehland and Bernhard, 2000) . The Rcs system has been intensively investigated by microbiological and mutational analysis. In contrast, many aspects of the structural organization of this system and its phosphotransfer reactions still have to be investigated. Recently, we reported the structures of the RcsD-HPt domain (Rogov et al., 2004) , the RcsC-PR domain, and of the novel RcsC-ABL domain (Rogov et al., 2006) . Here, we focus on the interface between RcsD and RcsB and report the discovery of the new domain RcsD-ABL, located N terminally to the HPt domain. We present the structure of this domain determined by liquid-state NMR spectroscopy and demonstrate that it interacts with RcsB. In addition we characterize the complex via analysis of chemical shift perturbations. We also compare the binding properties of RcsD-HPt and RcsD-ABL to RcsB, which provides insight into the function of the newly discovered domain RcsD-ABL.
RESULTS
Identification and Structure Determination of RcsD-ABL Analysis of the linker region between the HK and HPt domains of RcsD indicated the presence of a, so far, unknown structural region (residues 688-795). Secondary structure predictions in this region suggested the existence of both b strands and a helices. In order to characterize this potentially structured domain, we expressed it in E. coli and determined the three dimensional structure of this 13.3 kDa domain by liquid-state NMR spectroscopy (Figure 2A ). The statistics are summarized in Table 1 . The central structural element of the protein is a b sheet composed of six b strands with a b2-b1-b3-b4-b6-b5 topology. The b sheet is surrounded by two a helices: a1 and a2. Interestingly, the b strand b5 has an antiparallel orientation, whereas all other b strands form a parallel b sheet. This antiparallel b strand b5 contains charged arginine and glutamate residues, whereas the other five b strands are predominantly hydrophobic. In some of the calculated structures for RcsD-ABL, the loop L2 contains also a small 3 10 -helical section, including residues S741 and N742 following Pro 740. In analogy to the recently discovered ABL domain of RcsC, which was found to be an It comprises the components RcsF, RcsC, RcsD, RcsB, and RcsA. After the Rcs system has been activated by an external stimulus, probably via the lipoprotein RcsF, the hybrid sensor HK RcsC autophosphorylates via a conserved histidine residue. As indicated by the arrows, the phosphoryl group is transferred to the PR domain RcsC-PR and from there to the HPt domain of the protein RcsD. Finally, the phosphoryl group is transferred to the transcription factor RcsB. RcsB can either interact alone with the DNA via the RcsB-Box or in complex with RcsA via the RcsAB-Box. In contrast to RcsC, RcsD does not show autophosphorylation activity because the active site histidine residue is missing. To classify the fold of RcsD-ABL, we performed a structural similarity search using DALI and identified about 560 different structures with homology to RcsD-ABL. Most of the homologous structures belong to the flavodoxin-like fold, which consists of a five-stranded parallel b sheet sandwiched between two a-helical layers. This is the classical fold for response-regulator PR domains represented by the CheY-like superfamily. However, RcsD-ABL diverges from this classical PR domain fold by the presence of the sixth b strand, which replaces a helix a3 of a typical PR domain, and furthermore, by the replacement of a helices a1 and a2 with the loops L1 and L2.
Comparison of the RcsD-ABL and RcsC-ABL Domains Recently, we identified RcsC-ABL as a folded domain of RcsC (Rogov et al., 2006) . Figure 2 shows a comparison of the structures of the RcsD-ABL and RcsC-ABL domains. Both proteins are of similar size (RcsD-ABL: 13.3 kDa, residues 688-795; RcsC-ABL: 12 kDa, residues 705-805) and are located C terminal to their respective HK domains. Both structures consist of a central b sheet with two a helices located on one side (the five central b strands and the first a helix can be superimposed with an rmsd value of 1.43 Å ) (see Figure S1 available online). However, both structures differ in the number of b strands. As described above, RcsD-ABL contains five parallel b strands with a sixth b strand (b5) attached in an antiparallel orientation to b strand b6. The existence of a sixth antiparallel b strand is, so far, unique within the CheY super family. In RcsC-ABL this antiparallel b strand is replaced with the loop L3 connecting b4 and b5 (Figures 2 and 3 ). An important similarity between RcsC-ABL and RcsD-ABL is that the aspartic residue that forms the active site, and that accepts the phosphoryl group in classical PR domains, is missing, suggesting that it is unlikely that these ABL domains act as PR domains.
To search for other potential ABL domains, we screened the GenBank database for sequences homologous to RcsD-ABL. This search resulted in 20 entries with high similarity, all of which belong to potential sensor kinases from Enterobacteriaceae. The alignment of these potential ABL sequences from different species revealed a high conservation, except for the antiparallel-oriented b strand b5, which does not show any significant conservation. A comparable alignment of all potential ABL sequences with the RcsC-ABL sequence from E. coli shows only low conservation in the primary sequence ( Figure 3 ). It has been speculated that RcsC and RcsD form a heterodimeric unit . To investigate if this heterodimerization is promoted by the ABL domains of both proteins, we carried out NMR titration experiments with the isolated RcsC-ABL and RcsD-ABL domains. However, these experiments did not provide any evidence for interaction between the ABL domains ( Figure S2 ). Further interaction studies also indicated no interaction of the RcsD-ABL domain and the PR domain of RcsC or the HPt domain of RcsD. Interaction studies with the HK domains could not be carried out because expression of these domains in high amounts was not possible. The results obtained so far do not support a model in which the RcsD-ABL domain promotes domain-domain interaction within RcsD or between RcsD and RcsC.
Interaction of RcsD-ABL and RcsB-Characterization of the Binding Interfaces RcsD interacts not only with RcsC but also with the transcriptional regulator RcsB, which controls more than 150 different genes in E. coli (Hagiwara et al., 2003) . NMR titration experiments of the RcsD-ABL domain showed interaction with RcsB. RcsB is a classical transcription factor of bacterial two- component systems with homology to members of the LuxR family. It consists of a typical N-terminal PR domain with an a/b sandwich fold, the conserved aspartic residue Asp56 in the active center, and a C-terminal effector domain with a helix-turn-helix DNA-binding motif (Kahn and Ditta, 1991; Pristovsek et al., 2003; Robinson et al., 2000) . Unfortunately, so far, the full structural characterization of RcsB was not possible. While crystallization experiments have not been successful, only 60% of the residues, mainly in the C-terminal DNA-binding domain, could be assigned by NMR spectroscopy. Nevertheless the structure of the DNAbinding domain of the highly homologous RcsB protein from E. amylovora (Pristovsek et al., 2003) (but not of its PR domain) has been determined. To be able to interpret NMR-based titration experiments between the E. coli RcsB protein and the RcsD-ABL domain, we built a homology model of RcsB based on the DNA-binding domain from E. amylovora RcsB and on the PR domain of the homologous transcription factor NarL (Baikalov et al., 1996) (Figure S3 ). To characterize the interaction interface in the RcsD-ABL:RcsB complex, we first carried out NMR titration experiments with 15 N-labeled RcsD-ABL and unlabelled RcsB. Figure 4C shows an overlay of several titration steps, indicating that both proteins interact with each other and that this interaction is in fast exchange on the NMR timescale. Mapping the chemical shift differences onto the structure of RcsD-ABL demonstrated that the interaction interface includes the C-terminal end of helix a1, the following strand b2, and large parts of helix a2 ( Figure 4A ). To confirm the importance of the identified binding interface, we created the triple mutation N715A, Q776A, L780A. Investigating the interaction of this mutant with RcsB by isothermal titration calorimetry (ITC) showed a more than 10-fold increase of the dissociation constant compared with the wild-type protein ( Figure S4 ). Detailed analysis revealed that the signs of both the binding enthalpy and entropy changed relative to wild-type RcsD-ABL. Thus, binding of the mutant is entropy driven, characteristic for the replacement of polar interactions with hydrophobic ones.
We further wanted to analyze the interaction interface of RcsB with RcsD-ABL and used for this investigation the homology model mentioned above. Extensive optimization of buffer conditions allowed us to increase the number of peaks detectable in [ 15 N,
1 H]-TROSY-HSQC spectra to 80%; however, in triple resonance experiments the number of peaks observed was still quite low. Therefore, we used a fast mapping protocol in combination with the homology model to examine the interface without knowing the full backbone assignment of the protein (Reese and Dotsch, 2003 N-labeled amino acids, which allowed one to assign pairs of a 13 C-labeled amino acid directly followed by a 15 N-labeled one. Figure 4D shows a representative [ 15 N, 1 H]-TROSY-HSQC spectrum of RcsB labeled with 15 N-leucine, where nearly all leucine residues with differences in chemical shift could be identified by recording HNCO spectra of RcsB with selectively 13 C and 15 N-labeled amino acid combinations.
The results are summarized in Figure S5 . In this way we could identify the interaction interface of RcsB with RcsD-ABL in its effector domain, the DNA-binding domain. We could confirm this assignment by comparison with the [ 15 N, 1 H]-TROSY-HSQC spectrum of the highly homologous DNA-binding domain of E. amylovora, for which a complete backbone assignment is available. These results indicate that the interaction with the ABL domain is centered on helix a10 of the DNA-binding domain and additionally involves helix a7 and small parts of helix a8 ( Figure 4B ).
In Vivo Interaction of RcsD-ABL with RcsB Determined by b-Galactosidase Activity The interaction of RcsD-ABL with RcsB suggested that RcsD-ABL might be an interaction domain that is important for binding of RcsB to RcsD. Therefore, overproduction of RcsD-ABL in E. coli should disrupt the phosphorelay pathway. Based on this assumption, we analyzed the influence of RcsD-ABL expression on the transcriptional activity of RcsB by performing a b-galactosidase assay (Miller, 1972) . We used the strain DH300, which contains the rprA-lacZ insert. Because the binding of RcsB to the rprA promoter is independent of RcsA, we were able to investigate the RcsB/ RcsD-ABL interaction without interference from RcsA. To activate the RcsB pathway that should lead to a higher transcriptional activity of RcsB and a concomitant increase in the b-galactosidase activity, we used the antibiotic mecillinam (Laubacher and Ades, 2008) . First, E. coli DH300 cells were incubated with or without overexpression of RcsD-ABL with 0.3 mg/ml antibiotic for 1 hr at 37 C, after which the b-galactosidase test was performed with ONPG as a substrate. Wild-type E. coli DH300 showed a 9-fold increase in the b-galactosidase signal when activated with mecillinam. Induction of the RcsD-ABL plasmid with IPTG (1 mM) in the presence of mecillinam decreased the activity by 70% compared with the wild-type ( Figure 5 ). These results complement and support the proposed interaction of RcsB with RcsD-ABL in vivo.
Binding of RcsB to RcsD-ABL Enhances the Interaction between the RcsD-HPt and the RcsB-PR Domains
The experiments described above show that the RcsD-ABL domain interacts with the DNA-binding domain of RcsB. However, both domains are only indirectly involved in the phosphoryl transfer, probably by helping to form a complex between the RcsD-HPt domain and the RcsB-PR domain. Therefore, the phosphoryl-transfer complex most likely consists of the ABL and the HPt domain of RcsD and the PR and DNA-binding domain of RcsB. To investigate these additional interactions, we performed NMR titration experiments and ITC measurements with unlabelled RcsB and the three based on the data of the individual domains, whereas the linker was assigned manually. In contrast to the titration experiments with the single protein constructs RcsD-ABL (reported above) and RcsD-HPt (reported previously [Rogov et al., 2004] ) that showed fast exchange behavior, interaction of RcsB with the RcsD-ABL-HPt bidomain construct was in intermediate exchange, as suggested by significantly broadened resonances ( Figure 6B) . Furthermore, the binding interface on the bidomain differed slightly from the sum of the interfaces on the two individual domains. In the bidomain this interface included the linker region (residues Q789-D800).
The titration experiments reported above suggested that both the ABL and the HPt domains interact with RcsB and specifically that the ABL domain binds to the DNA-binding domain, and the HPt domain interacts with the PR domain of RcsB, which is further supported by the fact that the HPt and the PR domains are involved in the phosphoryl transfer. To further investigate this interaction, we performed again a fast mapping experiment with amino acid type selectively labeled RcsB and the RcsD-HPt domain. Although in the titration experiments with the RcsD-ABL domain we detected large chemical shift differences, we could detect only small differences in the titration experiments with the isolated RcsD-HPt domain, mainly located in the RcsB-PR domain. This result confirms the suggested model that the DNA-binding domain of RcsB interacts with the RcsD-ABL domain, whereas the HPt domain binds to the PR domain.
To obtain quantitative binding data, we performed ITC measurements at two different temperatures. The results are summarized in Figure 6A and Table 2 . RcsD-ABL bound to RcsB with a dissociation constant of $2 mM, whereas the binding constant for the HPt domain was $40 mM. Repeating the experiment with the bidomain RcsD-ABL-HPt resulted in a value of $10 mM using a one-site binding model for data analysis. This surprisingly weaker binding of the bidomain and the observation that the NMR experiments indicated stronger interaction prompted us to analyze the ITC data with a two-binding site model. This analysis showed that the interaction between the RcsD-ABL domain and RcsB basically does not change, whereas the interaction between the RcsD-HPt domain and RcsB becomes significantly stronger ($8 mM). In combination with the NMR titration data, these results suggest that the interaction between the RcsD-ABL domain and the DNA-binding domain of RcsB provides an important bridge between RcsD and RcsB that enhances the interaction between the PR and the HPt domains that are directly involved in the phosphoryl-transfer reaction.
DISCUSSION
In this article we report the identification of a new domain, named RcsD-ABL, in the membrane protein RcsD. This newly characterized domain is located N terminally to the HPt domain of RcsD and interacts with the effector domain of the transcription factor RcsB. We have analyzed the interaction interfaces of the RcsD-HPt and RcsD-ABL domains with their downstream-interaction partner, RcsB, which consists of a DNA-binding and a PR domain. To our knowledge, RcsD is only the second example of a sensor protein providing an extra domain as a binding site for a response regulator involved in two-component systems.
In this study it became apparent that the HK CheA and the hybrid HK-like protein RcsD show a similar arrangement of domains ( Figure S6 ). Structurally, both the RcsD-HPt and the CheA-P1 (HPt) domains show an up-down-up-down topology (Bilwes et al., 1999; Mourey et al., 2001 ). However, CheA-P1 serves not only as a phosphotransfer domain but also initiates via autophosphorylation the phosphotransfer cascade (Levit et al., 1999) , whereas RcsD contains an extra, but inactive, HK domain and, therefore, receives the phosphoryl group from the hybrid sensor HK RcsC . Similar to RcsD, CheA provides a separate domain, the CheA-P2 domain, as additional binding site for its response regulator, CheY . However, structurally, the CheA-P2 and RcsD-ABL domains are different. As described in detail in this article, the RcsD-ABL domain consists, with exception of b strand b5, exclusively of parallel b strands and parallel a helices. In contrast the CheA-P2 domain comprises a threestranded antiparallel b sheet and two antiparallel a helices . However, the most significant difference is the formation of the entire complex. In the case of the chemotaxis-signaling pathway, CheY consists only of a single PR domain, which interacts with CheA-P2 via the two a helices, a1 and a2, and brings the phosphoacceptor site of CheY in close proximity to the phosphorylated histidine residue on CheA-P1 (Stewart, 1997; Zhou et al., 1996) . However, the RcsD-ABL domain does not directly interact with the N-terminal PR domain of RcsB but instead interacts with the C-terminal DNA-binding domain, which acts as a tether to enable interaction between the RcsB-PR and RcsD-HPt domains. This arrangement is, so far, unique among His-Asp-His-Asp signaling cascades. Furthermore, the results indicate that in turn the RcsB DNAbinding domain is bifunctional and provides interfaces for specific DNA binding as well as for protein interactions.
Based on kinetic experiments, it was suggested that CheA-P2 brings CheY in close proximity to CheA-P1 to accelerate the phosphoryl transfer. Such acceleration is crucial for the chemotaxis system, which reacts to external stimuli within 50-100 ms; whereas most other two-component systems are coupled to transcription factors that mediate changes in protein expression levels over the course of minutes to hours (Stewart and Van Bruggen, 2004) . Based on our ITC and NMR titration experiments, we could show that the affinity of the RcsD-HPt domain to its response regulator RcsB is enhanced by the RcsD-ABL domain. These experiments have further revealed that the interaction affinity of RcsB to the RcsD-ABL domain is significantly stronger than to the RcsD-HPt domain (K D $2 versus $40 mM), suggesting that the RcsD-ABL domain plays a crucial role in the assembly of the active phosphoryl-transfer complex.
To obtain further insight into the interaction between RcsB and RcsD, we created a model of the RcsB effector domain docked onto the RcsD-ABL domain based on the observed chemical shift changes (Figure 7) . Unfortunately, lack of structural knowledge did not allow modeling of the entire four-domain complex ( Figure S6 ). One particular problem of trying to understand the interaction of all four domains on the structural level was the inability to obtain a structure of the PR domain of RcsB. Instead, we had to use a homology model that was based on the crystal structure of the transcription factor NarL. However, the structure of NarL represents a closed conformation, which 
Structure
Structure of the RcsD-ABL Domain upon phosphorylation, opens and becomes DNA-binding competent. A similar mechanism might trigger a conformational change in RcsB as well, which would lead to differences in the relative orientation of the RcsB-DNA binding domain and of the PR domain. Because we do not know the structure of the active conformation of RcsB, we have not tried to model the interaction of the RcsD-HPt and the RcsB-PR domain in the complex. Structures of complexes of HPt domains with PR domains are known from other phosphorelay systems, e.g., the Ypd1/Sln1-R1, the Spo0B/Spo0F complex ( Figure S6 ) (Xu et al., 2003; Zhao et al., 2008) , and the CheA 3 -P1/CheY 6 from R. sphaeroides (Bell et al., 2010) . However, the arrangement of four different domains in the active phosphoryl-transfer complex of the RcsC system is unique among all phosphorelay systems that have been investigated structurally so far.
The RcsC protein harbors with the RcsC-ABL domain, yet another similar domain that probably serves as an adaptor domain to enhance interaction with other, so far, unknown interaction partners. The function of the RcsC-ABL domain remains to be investigated.
EXPERIMENTAL PROCEDURES Cloning Procedures
All cloning steps were performed following standard protocols (Rogov et al., 2004) . Polymerase chain reactions were carried out using Vent R DNA Polymerase (New England BioLabs) and Pfu DNA Polymerase (Promega) for sitedirected mutagenesis. As a template the E. coli strain XL1 was used.
The DNA fragment encoding the RcsD-ABL domain spanning residues 688-795 of the RcsD protein was amplified by using the oligonucleotides RcsD-ABL-up CGGCCATGGAGCGTTTACTGGATGATGTCTGCG and RcsD-ABL-low CGGAGATCTCGATTCTGTCACCTCTTCCTGCGCC as primers. The DNA fragment was cloned with the restriction enzymes NcoI and BglII into the expression vector pQE60 (QIAGEN), resulting in the plasmid pQERcsD-ABL, including a C-terminal His 6 -tag.
Accordingly, a DNA fragment encoding the residues 688-890 of the RcsD protein and containing both the ABL and HPt domains was amplified with the oligonucleotides RcsD-ABLH-up CGGCCATGGAGCGTTTACTGGATGA TGTCTGCG and RcsDABH-low CCCTCGAGTCACAGCAAGCTCTT. The DNA fragment was cloned with the restriction enzymes BamHI and XhoI into the expression vector pET21a (Novagen), resulting in the plasmid pETRcsD-ABL-HPt containing an N-terminal T7 tag. glycerol. The cells were grown with intensive aeration slightly longer than the mid log phase (1.3-1.6 absorbance units at 600 nm) before IPTG was added to a final concentration of 1.0 mM. After 3 hr of induction, the cells were harvested, resuspended in buffer containing 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5% glycerol, and lysed using a French press. The cell debris was removed by centrifugation, and the lysate was loaded onto a Ni-affinity sepharose (Amersham Pharmacia Biotech) column. The column was washed with 200 ml of the same buffer, and pure protein was eluted with a linear gradient of imidazole (20-400 mM).
Protein Expression, Purification, and NMR Sample Preparations
The plasmid pET-RcsD-ABL-HPt was transformed into the BL21 (DE3) strain. Purification was carried out by anion exchange (50 mM Na 2 HPO 4 , 1 M NaCl gradient [pH 7.5]) and gelfiltration chromatography (50 mM Na 2 HPO 4 , 100 mM NaCl [pH 6.7] ). The E. coli RcsC-ABL, RcsC-PR, and RcsD-HPt domains and the RcsB protein were overproduced and purified as described (Kelm et al., 1997; Rogov et al., 2004 Rogov et al., , 2006 .
For the study of protein-protein interactions, samples were prepared by buffer exchange of the purified individual proteins using gel filtration with an HR16 Superdex75 column and subsequent co-concentration of the DH (kcal/mol) À15.5 ± 0.3 À1.8 ± 0.6 À6.4 ± 1 À10.6 ± 0.4 +1.6 ± 4
The fitting was performed with the one-site model for the single domains and with the two-site model for the RcsD-ABL-HPt bidomain. The RcsD-ABL domain, RcsB DNA-binding domain, and RcsB-PR domain are labeled. Only the RcsD-ABL and the DNA-binding domains of RcsB were used in the docking calculations. The structure of RcsB is a homology model based on the structure of the closed conformation of NarL. Additional information is available in Figure S6 .
RcsD-ABL/RcsB and RcsD-ABL-HPt/RcsB mixtures (50 mM Na 2 HPO 4 , 100 mM NaCl [pH 6.7] ). For the expression of selectively 13 C and/or 15 N-labeled RcsB, the auxotrophic strain DL39 was used, and purification followed the methods described above.
NMR Spectroscopy
NMR experiments to obtain resonance assignment of RcsD-ABL followed similar procedures as described (Rogov et al., 2006 (Rogov et al., , 2007 . Proton-proton distances for structure calculations were derived from 3D 13 C-separated and TROSY-type 15 N-separated NOESY experiments with the 13 C carrier position placed either in the aliphatic region, the methyl group region, or in the aromatic region. Spectra were obtained at 298 K on Bruker AVANCE spectrometers (Rheinstetten, Germany) operating at 1 H Larmor-frequencies of 600, 700, 800, and 900 MHz. Proton chemical shifts were referenced relative to internal DSS. The 15 N and 13 C chemical shifts were referenced indirectly using the consensus ratios (Wishart et al., 1995 
Structure Calculation
The NOE-based distance restraints were extracted from the 3D 13 C and 15 N-edited NOESY spectra using the CANDID module (Herrmann et al., 2002) of the CYANA (Guntert et al., 1997) program, version 1.0.5. The final structure calculation was performed using a simulated annealing protocol with torsion-angle dynamics (DYANA1.5) (Guntert et al., 1997) on the basis of 1590 unambiguous upper-limit restraints generated by CANDID. A total of 82 hydrogen bonds deduced from proton exchange data and CSI and TALOS programs were included as distance restraints (d HO % 2.1 Å and d NO % 3.1 Å ). In addition, 125 torsion-angle constraints were included as predicted by the program TALOS on the basis of chemical shift values. For the calculation of the final structure ensemble, 200 structures were calculated in 10,000 time steps per conformer. The 50 best DYANA conformers were refined in an explicit water shell (Linge et al., 2003) using the CNS software package (Brü nger et al., 1998) , and 25 structures with the lowest energy (about À4700 kcal/mol) were selected for validation using PROCHECK-NMR 3 (Laskowski et al., 1996) . The figures were prepared using the program PyMOL (DeLano Scientific LLC).
ITC ITC experiments were performed at 283 and 303 K in 50 mM Na 2 HPO 4 and 100 mM NaCl (pH 6.7) on a MicroCal VP-ITC device. For RcsB the concentration in the cell was 0.05 mM; for RcsD-ABL, RcsD-HPt, and RcsD-ABL-HPt, it was 0.6 mM (ratio 1:12). Data were analyzed with the standard program Origin 7 for ITC.
Upon titration of the RcsD-ABL domain into RcsB, we observed an additional process, which is centered at a molar ratio $0.5 and which is present both at 10 C and 30 C. We have interpreted this process as a change in the oligomeric state of RcsB (RcsB undergoes dimerization at concentrations used for ITC, shown by size-exclusion chromatography). We did not include this process into our fitting procedure; therefore, the experimental data and fitted curves deviate at the beginning.
b-Galactosidase Activity Cultures were grown in LB medium at 310 K overnight. The cultures were diluted 1:100 with fresh LB medium and were grown until an OD 600 of 0.2. At that point the antibiotic mecillinam (Sigma-Aldrich) was added to a concentration of 0.3 mg/ml as described (Laubacher and Ades, 2008) . After 60 min, the cells were harvested at 5500 rpm and resuspended in Z-buffer (100 mM sodium phosphate [pH 7.0], 10 mM KCl, 1 mM MgSO 4 , 50 mM b-mercaptoethanol). After that, the b-galactosidase assay was performed according to standard methods (Miller, 1972) .
Modeling
The homology model of RcsB was built by using the SWISS-model server in combination with the Deep Viewer (Guex and Peitsch, 1997) . First, the program applied a homology model of RcsB to the DNA-binding domain of E. amylovora and to the transcription factor NarL separately. Both structures were then combined in an overlay in the program Deep View, and the homology model was applied manually to RcsB. 
